N
NewAmsterdam Pharma Company NV
F:KH6
NewAmsterdam Pharma Company NV
F:KH6
Price:
23
EUR
-0.3%
Market Closed
Market Cap:
€110.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
N
|
NewAmsterdam Pharma Company NV
F:KH6
|
NL |
|
A
|
Apple Inc
MIL:AAPL
|
US |
|
C
|
CeriBell Inc
NASDAQ:CBLL
|
US |
Wall St Price Targets
KH6 Price Targets Summary
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV
Wall Street analysts forecast KH6 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for KH6 is 56.42 EUR with a low forecast of 40.88 EUR and a high forecast of 67.1 EUR.
Lowest Forecast
Price Target
40.88
EUR
78% Upside
Average Forecast
Price Target
56.42
EUR
145% Upside
Highest Forecast
Price Target
67.1
EUR
192% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is KH6's stock price target?
Price Target
56.42
EUR
56.42
EUR
According to Wall Street analysts, the average 1-year price target for KH6 is 56.42 EUR with a low forecast of 40.88 EUR and a high forecast of 67.1 EUR.
What is the Revenue forecast for NewAmsterdam Pharma Company NV?
Projected CAGR
32%
32%
The compound annual growth rate for Revenue over the next 11 years is 32%.
